Please read the article attached. I just thought to share as your work has contributed to this success. The CVO study has to be completed before the ITCA can go to market. As you may know, the most critical aspect of a Clinical trial is the enrollment. The last 6 months on the CVO study has been an amazing story of rebound and the your successful implementation of the Rejuvenation meetings contributed to the uptick in study enrollment. We have now Completed our enrollment Target – 5 months ahead of target! This is one of the best outcomes I have seen in my career.
We have expanded our services under the mdgroup umbrella and currently are working on a new website to reflect this offering. Please contact a member of the team for any inquiries.